Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Liminatus Pharma, Inc.

NASDAQ: LIMN · Life Sciences · 2 alerts · CIK 1971387

Share price
$2.97Close, Nov 16
Market cap
$199M
Shares outstanding
67.16MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Liminatus Pharma, Inc. filings on SEC EDGAR ↗

4:16 PM ET 8-K
Capital Raise

Liminatus Pharma Capital Raise of $650K

Liminatus Pharma entered into a subscription agreement with a non-U.S. investor for a private placement of 260,001 shares of common stock. The company raised gross proceeds of approximately $0.65 million at a price of $2.50 per share. The proceeds are intended for working capital and general corporate purposes.

Value
$650K
9:16 AM ET 8-K
Nasdaq/NYSE Compliance Notice

Liminatus Pharma Nasdaq/NYSE Compliance Notice

Liminatus Pharma has regained compliance with Nasdaq's minimum bid price requirement after its common stock maintained a closing bid price above $1.00 for 13 consecutive trading days. The company previously effected a 1-for-50 reverse stock split on August 20, 2026, to address the deficiency. Nasdaq has officially closed the matter, and the company remains listed on The Nasdaq Capital Market.

Counterparty
Nasdaq

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.